HUANG Fen, MENG Fan-yi, XUE Bing, LIU xiao-li, ZHANG yu, YE Chang-xiong, ZHANG Xian. Therapeutic effects of chemotherapeutic regimen with pirarubicin for adult high-risk acute leukemia[J]. Journal of Southern Medical University, 2004, 24(07): 768-770.
[1] 张之南.血液学诊断及疗效标准[M].北京:科学出版社,1998.171-94. [2] Umezawa H, Takahashi Y, Kinoshita M, et al. Tetrahydropyranyl derivative of daunomycin and adriamycin [J]. J Antibiot, 1979, 32(10): 1082-4. [3] Tsukagoshi S. Pirarubicin (THP-adriamycin). Gan To Kagaku Ryoho[J]. 1988, 15(9): 2819-27. [4] 钟建庭,达万明,张茜,等.吡柔比星联合化疗方案治疗急性白血病24例临床观察[J].癌症,1996,15(6):449-51.Zhong JT, Da WM, Zhang Q, et al. Pirarubicin combination on chemotherapy in the treatment of acute leukemia[J]. Chin J Cancer,1996, 15(6): 449-51. [5] 高冲,孙耘玉,金宝翠.吡喃阿霉素为主方案治疗难治和复发性急性白血病[J].肿瘤防治研究,1998,25(1):55-7.Gao C, Sun YY, Jin BC. Treatment of relapsed and refractory acute leukemia with regimens THP[J]. Cancer Res Prev Treat, 1998, 25(1): 55-7. [6] 周卫青.以吡柔比星为主的方案治疗难治和复发性急性淋巴细胞白血病11例疗效观察[J].肿瘤研究与临床(CancerRes Clin),2001,13(6):382.